THE PROGNOSTING VALUE OF COMBING NEW BIOMARKERS FOR REMOTE CARDIOVASCULAR ENDPOINTS RISK STRATIFICATION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION

ZAGIDULLIN, N.SH.; HAMITOVA, A.; LAKMAN, I.; KRIONI, I.; GAREEVA, D.; ZULKARNEEV, R.; TULBAEV, E.

THE PROGNOSTING VALUE OF COMBING NEW BIOMARKERS FOR REMOTE CARDIOVASCULAR ENDPOINTS RISK STRATIFICATION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION

ZAGIDULLIN, N.SH., HAMITOVA, A., LAKMAN, I., KRIONI, I., GAREEVA, D., ZULKARNEEV, R., TULBAEV, E.

Publication date: 2020

Abstract:

The biomarkes NT-proBNP, ST2 and Pentraxin-3 (Ptx-3) have emerged as potential powerful tools in stratifying the risk of unfavorable cardiovascular events in cardiac patients in post-MI period. Goal was to investigate the potential prognostic power of the biomarkers ST2, Ptx-3 andNT-proBNP in cardiovascular events risk stratification in 2 years FU after STEMI.

Keywords:
The biomarkes NT-proBNP, ST2 and Pentraxin-3 (Ptx-3), Web of Science

Издатель: Elsevier Science Publishing Company, Inc.

Тип: Article

THE PROGNOSTING VALUE OF COMBING NEW BIOMARKERS FOR REMOTE CARDIOVASCULAR ENDPOINTS RISK STRATIFICATION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION

Фасеты

Оппонент

Научный руководитель

Авторы

Ключевые слова

Год